Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-16 Purchase | 2020-03-16 5:15 pm | IMARA Inc. | IMRA | Agger Mette Kirstine Director 10% Owner | 187,500 | $16 | $3,000,000 | 1,448,179 (Indirect Direct) | View |
| 2019-05-09 Purchase | 2019-05-13 5:01 pm | Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director | 375,000 | $10 | $3,750,000 | 1,151,544 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-02 Option Award | 2024-02-06 5:57 pm | N/A 2034-02-01 | Lexeo Therapeutics Inc. | LXEO | Agger Mette Kirstine Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:15 pm | N/A 2033-06-06 | scPharmaceuticals Inc. | SCPH | Agger Mette Kirstine Director | 17,300 | $0 | 17,300 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 4:18 pm | N/A 2030-06-09 | scPharmaceuticals Inc. | SCPH | Agger Mette Kirstine Director | 6,124 | $0 | 6,124 (Direct) | View |
| 2020-03-16 Conversion | 2020-03-16 5:15 pm | N/A N/A | IMARA Inc. | IMRA | Agger Mette Kirstine Director 10% Owner | 9,088,907 | $0 | 1,448,179 (Indirect) | View |
| 2020-03-16 Option Award | 2020-03-16 5:15 pm | N/A 2030-03-15 | IMARA Inc. | IMRA | Agger Mette Kirstine Director 10% Owner | 15,457 | $0 | 1,448,179 (Direct) | View |
Ownership | 2020-03-11 6:21 pm | N/A N/A | IMARA Inc. | IMRA | Agger Mette Kirstine Director 10% Owner | 0 | $0 | 1,245,222 (Indirect) | View |
| 2019-06-18 Option Award | 2019-06-20 4:18 pm | 2020-06-18 2029-06-18 | scPharmaceuticals Inc. | SCPH | Agger Mette Kirstine Director | 6,124 | $0 | 6,124 (Direct) | View |
| 2019-05-09 Conversion | 2019-05-13 5:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director | 7,625,859 | $0 | 1,151,544 (Indirect) | View |
| 2019-05-07 Option Award | 2019-05-08 5:00 pm | N/A 2029-05-06 | Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director | 23,684 | $0 | 23,684 (Direct) | View |
Ownership | 2019-05-07 7:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Agger Mette Kirstine Director | 0 | $0 | 776,307 (Indirect) | View |